Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Neuropathol Appl Neurobiol ; 38(5): 471-86, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22044361

ABSTRACT

AIMS: CLN8 deficiency underlies one of a group of devastating childhood neurodegenerative disorders, the neuronal ceroid lipofuscinoses. The function of the CLN8 protein is currently unknown, but a role in lipid metabolism has been proposed. In human CLN8 diseased brains, alterations in lipid composition have been detected. To further investigate the connection of CLN8 to lipid metabolism, we characterized the lipid composition of early symptomatic Cln8-deficient mouse (Cln8(mnd)) brains. METHODS: For lipid profiling, Cln8(mnd) cerebral cortical tissue was analysed by liquid chromatography/mass spectrometry. Galactolipid synthesis was measured through enzyme activity and real-time mRNA expression analyses. Based on the findings, myelination and white matter integrity were studied by immunohistochemistry, stereological methods, electron microscopy and magnetic resonance imaging. The development of myelin-forming oligodendrocytes was also studied in vitro. RESULTS: Sphingolipid profiling showed a selective reduction in myelin-enriched galactolipids. The mRNA expression and activity of UDP-galactose:ceramide galactosyltransferase (CGT), the key enzyme in the galactolipid synthesis, was reduced in the Cln8(mnd) brain. Expression of oligodendrocyte markers suggests a maturation defect. The amount of myelin was reduced in 1-month-old Cln8(mnd) mice, but reached normal levels by 5 months of age. The level of Cln8 gene expression followed the developmental pattern of myelin formation and was high in primary oligodendrocytes. CONCLUSIONS: Taken together, these observations suggest that galactolipid deficiency and delayed myelin maturation characterize the early CLN8 disease pathogenesis through a maturation defect of oligodendrocytes.


Subject(s)
Axons , Membrane Proteins/metabolism , Neuronal Ceroid-Lipofuscinoses/metabolism , Oligodendroglia/metabolism , Animals , Axons/metabolism , Axons/ultrastructure , Brain/metabolism , Brain/pathology , Cell Differentiation , Cells, Cultured , Disease Models, Animal , Membrane Proteins/deficiency , Mice , Mice, Knockout , Myelin Sheath/genetics , Myelin Sheath/pathology , Neuronal Ceroid-Lipofuscinoses/genetics , Neuronal Ceroid-Lipofuscinoses/pathology , Oligodendroglia/cytology , Time Factors
2.
Hum Mol Genet ; 10(19): 2123-31, 2001 Sep 15.
Article in English | MEDLINE | ID: mdl-11590129

ABSTRACT

Batten disease (juvenile neuronal ceroid lipofuscinosis, JNCL), the most common neurodegenerative disease of childhood, is caused by mutations in the CLN3 gene encoding a putative transmembrane protein. The function of CLN3 is currently unknown but it has been shown to localize in the endosomal/lysosomal compartments of non-neuronal cells. In addition, several other intracellular localizations have been proposed and the controversy of the reports suggests that CLN3 may have different intracellular localization in different cell types. Batten disease severely affects neuronal cells but leaves other organs clinically unaffected, and thus it is of utmost importance to approach the disease mechanism by studying the expression and localization of CLN3 in the brain and neuronal cells. We have analysed here CLN3 in the mouse brain using in situ hybridization, immunohistochemical staining and western blot analysis of subcellular fractions. As visual deterioration is the hallmark of Batten disease we have set up primary retinal cultures from the mouse and analysed both endogenous mouse CLN3 and Semliki Forest virus-mediated human CLN3 localization using immunofluorescence staining and confocal microscopy. We demonstrate that CLN3 is abundantly expressed in neuronal cells, especially in the cortex, hippocampus and cerebellum of the adult mouse brain. Furthermore, our results indicate that in neurons CLN3 is not solely a lysosomal protein. It is localized in the synaptosomes but, interestingly, is not targeted to the synaptic vesicles. The novel localization of CLN3 directs attention towards molecular alterations at the synapses. This should yield important clues about the mechanisms of neurodegeneration in Batten disease.


Subject(s)
Brain/metabolism , Molecular Chaperones , Neuronal Ceroid-Lipofuscinoses/metabolism , Proteins/metabolism , Synapses/metabolism , Synaptic Vesicles/metabolism , Animals , Blotting, Western , Fluorescent Antibody Technique, Indirect , GAP-43 Protein/metabolism , Genetic Vectors , Humans , In Situ Hybridization, Fluorescence , Intracellular Signaling Peptides and Proteins , Membrane Glycoproteins/metabolism , Mice , Mice, Inbred C57BL , Microscopy, Confocal , Nerve Tissue Proteins/metabolism , Phosphoprotein Phosphatases/metabolism , Protein Tyrosine Phosphatase, Non-Receptor Type 6 , Protein Tyrosine Phosphatases/metabolism , Proteins/genetics , Retina/metabolism , Semliki forest virus/genetics , Transfection
3.
Mol Cell Neurosci ; 18(2): 131-40, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11520175

ABSTRACT

Infantile neuronal ceroid lipofuscinosis (INCL) is a severe neurodegenerative storage disorder in children caused by mutations in the palmitoyl protein thioesterase gene (PPT1). We have investigated here four naturally occurring previously described PPT1 mutations and show that all cause severe effects on PPT1 enzyme activity in transiently transfected COS-1 cells. Two of the mutations (delPhe84 and insCys45) cause a classical INCL phenotype and two (Thr75Pro and Leu219Gln) result in a late onset disease phenotype. All these mutated PPT1 molecules have severely altered intracellular localization in transiently transfected BHK-cells, whereas in mouse primary neuron cultures different effects were observed. In neurons the delPhe84 and insCys45 mutant polypeptides were targeted to the ER. Interestingly the Thr75Pro and Leu219Gln mutations had only minor effects on the neuronal trafficking of PPT1 and the mutated polypeptides were observed in neuronal shafts and showed colocalization with the presynaptic marker SV2. Our data indicates that neuronal cells provide an excellent model to study the genotype-phenotype correlation in INCL.


Subject(s)
Models, Biological , Mutation/physiology , Neuronal Ceroid-Lipofuscinoses/enzymology , Neuronal Ceroid-Lipofuscinoses/genetics , Neurons/metabolism , Palmitoyl-CoA Hydrolase/genetics , Palmitoyl-CoA Hydrolase/metabolism , Protein Transport/genetics , Age of Onset , Animals , COS Cells/metabolism , COS Cells/ultrastructure , Cricetinae , Disease Progression , Endoplasmic Reticulum/metabolism , Fetus , Fluorescent Antibody Technique , Golgi Apparatus/metabolism , Humans , Mice , Microscopy, Electron , Neuronal Ceroid-Lipofuscinoses/physiopathology , Phenotype , Recombinant Proteins/genetics , Recombinant Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...